BOWIE ALFRED LLOYD JR. enters EIKON THERAPEUTICS, INC. with 51.57K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/4/2026ACC: 0001193125-26-038167
Officer· Chief Financial Officer
Since Mar 2026
51.57K
Baseline shares
100% direct
51.57K
Direct ownership
1 position
179.06K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned51.57K
Total
51.57K direct51.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 51.57K | Direct |
| Total | 51.57K | 51.57K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
55.70K
Shares owned
N/A
Exercise price
1.94
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
33.52K
Shares owned
N/A
Exercise price
9.85
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
26.15K
Shares owned
N/A
Exercise price
9.85
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
63.69K
Shares owned
N/A
Exercise price
9.85
Expiration
—
Exercise window
—
Total
Underlying
179.06K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.94 | — | — | 55.70K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.85 | — | — | 33.52K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.85 | — | — | 26.15K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.85 | — | — | 63.69K | N/A |
| Total | 179.06K | 0.00 | ||||